Search the MBS

Multiparametric Magnetic Resonance Imaging scan of the prostate for the assessment of cancer, if the patient is referred by an urologist, radiation oncologist, or medical oncologist and:

 the request for the scan identifies: 
(i) the patient is under active surveillance following a confirmed diagnosis of prostate cancer by biopsy histopathology; and
(ii) the patient is not planning or undergoing treatment for prostate cancer.
using a standardised image acquisition protocol involving T2 Weighted Imaging, Diffusion Weighted Imaging, and Dynamic Contrast Enhancement (unless contraindicated)
(R) 

Note: Benefits are payable at the time of diagnosis of prostate cancer, 12 months following diagnosis and then every 3rd year thereafter or at any time, if there is a clinical concern, including PSA progression.  This item is not to be used for the purposes of treatment planning or for monitoring after treatment.

Bulk bill incentive

Fee: $450.00 Benefit: 75% = $337.50 85% = $382.50

(See para IN.0.19 of explanatory notes to this Category)

• Previous - Item 63541
• Next - Item 63545